These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17580501)

  • 1. Radiotherapy in the HAART era: a cause for concern?
    Bridgewater C; Cottrill C; Ahmed I
    J HIV Ther; 2006 Sep; 11(3):61-3. PubMed ID: 17580501
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of HAART for biological tumour therapy.
    Monini P; Toschi E; Sgadari C; Bacigalupo I; Palladino C; Carlei D; Barillari G; Ensoli B
    J HIV Ther; 2006 Sep; 11(3):53-6. PubMed ID: 17580499
    [No Abstract]   [Full Text] [Related]  

  • 3. How does HIV impact on non-AIDS events in the era of HAART?
    Barber TJ; Hughes A; Dinsmore WW; Phillips A
    Int J STD AIDS; 2009 Jan; 20(1):1-3. PubMed ID: 19103883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of depression on HIV outcomes in the HAART era.
    Hartzell JD; Janke IE; Weintrob AC
    J Antimicrob Chemother; 2008 Aug; 62(2):246-55. PubMed ID: 18456650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
    Hung CC; Hung MN; Hsueh PR; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Huang YT; Lo YC; Hsiao CF; Chang SC
    Clin Infect Dis; 2007 Sep; 45(5):e60-7. PubMed ID: 17682981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncology impact of highly active antiretroviral therapy.
    Schlichemeyer R; Chambers C; Gill MJ
    J Oncol Pharm Pract; 2007 Mar; 13(1):17-25. PubMed ID: 17621563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cutaneous drug reactions in HIV-infected patients in the HAART era].
    Blanes M; Belinchón I; Portilla J
    Actas Dermosifiliogr; 2009 May; 100(4):253-65. PubMed ID: 19463228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era.
    Nguyen BY; Reveille JD
    Curr Opin Rheumatol; 2009 Jul; 21(4):404-10. PubMed ID: 19444116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART.
    Chiappini E; Galli L; Tovo PA; Gabiano C; Lisi C; Gattinara GC; Esposito S; Viganò A; Giaquinto C; Rosso R; Guarino A; de Martino M
    AIDS; 2007 Jul; 21(12):1607-15. PubMed ID: 17630556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of HAART therapy on co-infection of tuberculosis and HIV cases for 9 years in Taiwan.
    Tseng SH; Jiang DD; Hoi HS; Yang SL; Hwang KP
    Am J Trop Med Hyg; 2009 Apr; 80(4):675-7. PubMed ID: 19346398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What you can see in your patient's eyes? Review of ocular manifestations of HIV in HAART era.
    Nasoodi A; Lim LT; Al-Ani A; Quah S; Dinsmore WW
    Int J STD AIDS; 2008 Jan; 19(1):4-11. PubMed ID: 18275637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of HIV-associated pulmonary arterial hypertension: trends in the HAART era.
    Opravil M; Sereni D
    AIDS; 2008 Sep; 22 Suppl 3():S35-40. PubMed ID: 18845920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era.
    dos Santos Pinheiro R; França TT; Ribeiro CM; Leão JC; de Souza IP; Castro GF
    J Oral Pathol Med; 2009 Sep; 38(8):613-22. PubMed ID: 19614862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New spectrum of HIV-associated cognitive disorders in the HAART era].
    Du Pasquier R; Cavassini M; Simioni S; Annoni JM; Giacobini E; Hirschel B
    Rev Med Suisse; 2009 Apr; 5(201):955-6, 958-61. PubMed ID: 19476058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isosporiasis in patients with HIV infection in the highly active antiretroviral therapy era in France.
    Lagrange-Xélot M; Porcher R; Sarfati C; de Castro N; Carel O; Magnier JD; Delcey V; Molina JM
    HIV Med; 2008 Feb; 9(2):126-30. PubMed ID: 18257775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal complications of HIV infection: changing priorities in the HAART era.
    Wilcox CM; Saag MS
    Gut; 2008 Jun; 57(6):861-70. PubMed ID: 18203808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Vogel M; Rockstroh JK
    Curr Opin HIV AIDS; 2009 May; 4(3):171-5. PubMed ID: 19532046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.
    Shah SU; Kerkar SP; Pazare AR
    Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between oral Kaposi 's sarcoma and HAART: contribution of two case reports.
    Campo-Trapero J; Del Romero-Guerrero J; Cano-Sánchez J; Rodríguez-Martín C; Martínez-González JM; Bascones-Martínez A
    Med Oral Patol Oral Cir Bucal; 2008 Nov; 13(11):E709-13. PubMed ID: 18978711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study.
    Pantanowitz L; Bohac G; Cooley TP; Aboulafia D; Dezube BJ
    BJU Int; 2008 Jun; 101(12):1519-23. PubMed ID: 18384640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.